This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Lorus Therapeutics Inc., Aptose Biosciences Inc., Aptose Boisciences Inc.. Active years: 2011-2018.
Company Filing History:
4 out of 10 
2 out of 6 
1 out of 1 Years Active: 2011-2018
Title: **Innovator in Cancer Research: Mario Huesca**
Introduction
Mario Huesca is a prominent inventor based in Toronto, Canada, known for his contributions to cancer research through innovative pharmaceutical compounds. With a total of seven patents to his name, Huesca's work is a significant advancement in the development of anti-cancer agents.
Latest Patents
Huesca's latest patents include groundbreaking compounds such as "Aryl imidazoles and their use as anti-cancer agents." This patent details therapeutically effective 2,4,5-trisubstituted imidazole compounds, providing methods for their preparation and the pharmaceutical compositions that incorporate them. The innovation highlights their potential as anti-cancer agents, detailing specific chemical structures and their various substituents, illustrating the complexity and adaptability of these compounds.
Another notable patent by Huesca is for "2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer." This invention outlines compounds that inhibit the proliferation of several cancer cell types, including those associated with renal, pancreatic, prostate, colon cancers, leukemia, as well as brain tumors and non-small cell lung cancer.
Career Highlights
Throughout his career, Mario Huesca has collaborated with esteemed companies in the biotechnology sector such as Lorus Therapeutics Inc. and Aptose Biosciences Inc. His contributions to these organizations have played a pivotal role in advancing research and therapeutic strategies targeting cancer treatment.
Collaborations
Among his notable coworkers are Aiping H Young and Yoon S Lee, who have worked alongside him in developing these innovative compounds. Their collaborative efforts have enriched the research environment and facilitated the successful progression of various projects aimed at combating cancer.
Conclusion
Mario Huesca stands out as an influential inventor in the field of cancer therapeutics. His dedication to research and development, along with his innovative patent contributions, has positioned him as a key figure in the ongoing battle against cancer, offering hope through scientifically advanced solutions.